Idera Pharmaceuticals to Present at the Baird 2019 Global Healthcare Conference
August 30 2019 - 12:00PM
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that the
company will present at the Baird 2019 Global Healthcare Conference
on Wednesday, September 4, 2019 at 8:30 a.m. Eastern Time at the
InterContinental New York Barclay Hotel.
A live audio webcast of Idera’s presentation will
be accessible in the Investors and Media section of Idera’s website
at http://www.iderapharma.com. An archived version will also be
available on the company’s website after the event for 90
days.
About Idera
PharmaceuticalsHarnessing the approach of the earliest
researchers in immunotherapy and the Company’s vast experience in
developing proprietary immunology platforms, Idera’s lead
development program is focused on priming the immune system to play
a more powerful role in fighting cancer, ultimately increasing the
number of people who can benefit from immunotherapy. Idera also
continues to focus on the acquisition, development and ultimate
commercialization of drug candidates for both oncology and rare
disease indications characterized by small, well-defined patient
populations with serious unmet needs. To learn more about Idera,
visit www.iderapharma.com.
IDERA PHARMACEUTICALS Contact: Robert A. Doody,
Jr.SVP, Investor Relations & CommunicationsPhone (484)
348-1677RDOODY@IDERAPHARMA.COM
Idera Pharmaceuticals (NASDAQ:IDRA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Idera Pharmaceuticals (NASDAQ:IDRA)
Historical Stock Chart
From Apr 2023 to Apr 2024